Teladoc Health Inc (TDOC) Holdings Cut by Lisanti Capital Growth LLC

Lisanti Capital Growth LLC trimmed its position in shares of Teladoc Health Inc (NYSE:TDOC) by 27.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,215 shares of the health services provider’s stock after selling 14,759 shares during the period. Lisanti Capital Growth LLC’s holdings in Teladoc Health were worth $3,386,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd bought a new stake in Teladoc Health during the third quarter valued at about $165,000. We Are One Seven LLC acquired a new position in shares of Teladoc Health during the third quarter valued at about $225,000. Atria Investments LLC acquired a new position in shares of Teladoc Health during the third quarter valued at about $228,000. FineMark National Bank & Trust acquired a new position in shares of Teladoc Health during the third quarter valued at about $261,000. Finally, Bradley Foster & Sargent Inc. CT acquired a new position in shares of Teladoc Health during the third quarter valued at about $263,000.

TDOC has been the subject of a number of research analyst reports. Cantor Fitzgerald reaffirmed a “hold” rating and set a $52.00 price objective on shares of Teladoc Health in a research report on Wednesday, August 1st. Wells Fargo & Co reaffirmed a “buy” rating and set a $70.00 price objective on shares of Teladoc Health in a research report on Thursday, August 2nd. KeyCorp upped their price objective on shares of Teladoc Health from $74.00 to $90.00 and gave the company an “overweight” rating in a research report on Monday, August 27th. MED increased their price target on shares of Teladoc Health from $68.00 to $89.00 and gave the stock an “outperform” rating in a research report on Friday, September 28th. Finally, Citigroup increased their price target on shares of Teladoc Health from $80.00 to $88.00 and gave the stock a “buy” rating in a research report on Friday, September 21st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $82.95.

Shares of Teladoc Health stock opened at $68.28 on Thursday. The company has a current ratio of 8.99, a quick ratio of 8.99 and a debt-to-equity ratio of 0.40. The stock has a market cap of $4.45 billion, a price-to-earnings ratio of -41.38 and a beta of 0.96. Teladoc Health Inc has a 1-year low of $27.30 and a 1-year high of $89.05.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Thursday, November 1st. The health services provider reported ($0.34) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.36) by $0.02. The firm had revenue of $111.00 million for the quarter, compared to analysts’ expectations of $109.94 million. Teladoc Health had a negative net margin of 31.32% and a negative return on equity of 14.05%. The company’s quarterly revenue was up 61.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.55) earnings per share. As a group, equities analysts anticipate that Teladoc Health Inc will post -1.47 EPS for the current year.

In related news, President Peter A. Mcclennen sold 69,224 shares of Teladoc Health stock in a transaction dated Monday, November 5th. The shares were sold at an average price of $66.77, for a total transaction of $4,622,086.48. Following the completion of the sale, the president now owns 12,692 shares of the company’s stock, valued at approximately $847,444.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jason N. Gorevic sold 25,000 shares of Teladoc Health stock in a transaction dated Thursday, August 16th. The stock was sold at an average price of $71.66, for a total transaction of $1,791,500.00. Following the sale, the chief executive officer now directly owns 561,184 shares of the company’s stock, valued at approximately $40,214,445.44. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 230,381 shares of company stock worth $16,661,145. Insiders own 3.95% of the company’s stock.

WARNING: This report was first published by WKRB News and is owned by of WKRB News. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://www.wkrb13.com/2018/11/08/teladoc-health-inc-tdoc-holdings-cut-by-lisanti-capital-growth-llc.html.

About Teladoc Health

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Article: What is the Ex-Dividend Date in Investing?

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply